Helmerich & Payne (NYSE:HP) Stock, Quote.Headers.trade-ideas

Helmerich & Payne

Helmerich & Payne maintains one of the largest fleets of land drilling rigs in the US. The company's FlexRig line is the leading choice to drill horizontal wells for production of US tight oil and gas. H&P is present in nearly every major US shale play and has a small but growing presence internationally.

Movers

News

Intraday Update

Markets

Trading Ideas

ASTS

ATPC

BALY

BLMZ

CERO

COOP

CTNT

EZFL

FORM

GSHD

HOTH

INDV

JBHT

KALU

KDLY

LULU

PEGA

PLXS

POAI

RBBN

SHYF

SLGL

SLNA

SLRX

STLA

TIVC

TWOU

VKTX

XCUR

Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Business,Man,Sign,A,Contract,Investment,Professional,Document,Agreement.,Meeting

Equities

Mid Cap

PSCE

SPDR S&P Oil & Gas Equipment & Services ETF

Helmerich &amp; Payne acquires KCA Deutag for $1.9725 billion, expanding its Middle East operations and boosting cash flow.

Helmerich &amp; Payne Makes Big Bet on Middle East with ~$2B KCA Deutag Acquisition

IBM Investment

BEAM

CBRE

MORN

NDAQ

VSAT

IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich &amp; Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday

Helmerich & Payne Inc

Henley Park Acquisition Corp

CHINA HIGH PRCSN AUTOMT by CHINA HIGH PRECISION AUTOMATION GROUP LIMITED

China High Precision Automation Group Ltd

High Performance Blockchain

Hempacco Co Inc

HOME PRODS CNTR PCL FGN by Home Products Center Public Co., Ltd.

Home Product Center PCL

Home Product Center PCL Units Non-voting Depository Receipt

HOPSON DEVELOPMENT HLDG by Hopson Development Holdings Ltd.

Hopson Development Holdings Ltd

Hewlett Packard Enterprise Company Common Stock

Hewlett Packard Enterprise Co

John Hancock Pfd Income Fund II Pfd Income Fund II

John Hancock Preferred Income Fund II

Hapag-Lloyd AG

HIPGNOSIS SONGS FD LTD by HIPGNOSIS SONGS FD LTD.

Highest Performances Holdings Inc. - American Depository Shares

Highest Performances Holdings Inc

HAMAMATSU PHOTONICS ORD by Hamamatsu Photonics

Hamamatsu Photonics KK

HAMAMATSU PHOTONICS ADR by Hamamatsu Photonics

John Hancock Preferred Income Fund Common Shares of Beneficial Interest

John Hancock Preferred Income Fund

HUADIAN PWR INTL CORP ORD by Huadian Power International Corp.

Huadian Power International Corp Ltd

HUADIAN PWR INTL UNSP/ADR by Huadian Power International Corp.

HPIL Holding

HighPeak Energy Inc

HORIZON PETROLEUM LTD by Horizon Pete Ltd

Horizon Petroleum Ltd

HOSKEN PASSENGER LOGISTIC by HOSKEN PASSENGER LOGISTICS & RAIL LTD.

Frontier Transport Holdings Ltd

AFRICA ENERGY CORP by Africa Energy Corp.

Africa Energy Corp

Hemp Naturals Inc

Hop-On Inc

Hudson Pacific Properties, Inc. Common Stock

Hudson Pacific Properties Inc

Hudson Pacific Properties, Inc. 4.750% Series C Cumulative Redeemable Preferred Stock

HP Inc

HPQ Silicon Inc

John Hancock Preferred Income Fund III Preferred Income Fund III

John Hancock Preferred Income Fund III

HYBRID PWR SOLUTIONS INC by Hybrid Power Solutions Inc.

Hybrid Power Solutions Inc

Hempstract Inc

Huobi Pool Token

HAPPY TOWN HOLDINGS by Happy Town Holdings Inc.

Happy Town Holdings Inc

hopTo Inc

Hexagon Purus ASA

HAPPY CREEK MINERALS LTD by Happy Creek Minerals Ltd.

Happy Creek Minerals Ltd

RBC Capital analyst Keith Mackey maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Sector Perform and raises the price target from $48 to $50.

Price Target

Analyst Ratings

RBC Capital Maintains Sector Perform on Helmerich & Payne, Raises Price Target to $50

Shares of Edwards Lifesciences Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) fell sharply during Thursday's session after the company reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired <a href="https://www.benzinga.com/quote/EW/earnings">JenaValve and Endotronix</a>.
Edwards Lifesciences reported quarterly earnings of 70 cents per share which beat the analyst consensus estimate of 69 cents per share. The company reported quarterly sales of $1.632 billion which missed the analyst consensus estimate of $1.653 billion.
Edwards Lifesciences shares dipped 26.9% to $63.60 on Thursday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Predictive Oncology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POAI#NASDAQ">POAI</a>) shares jumped 85% to $1.96 after the company entered biomarker discovery market after successful retrospective ovarian cancer study yields compelling results.</li>
<li>Psyence Biomedical Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBM#NASDAQ">PBM</a>) rose 65.4% to $0.6424 after the company announced the export of nature-derived psilocybin to Australia and said a trial is projected to be initiated shortly following receipt of drug product by trial sites.</li>
<li>Salarius Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) jumped 60% to $3.4421.</li>
<li>Goosehead Insurance, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) rose 29.8% to $85.25 following upbeat second-quarter results.</li>
<li>Viking Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) shares gained 28.2% to $64.64 after the company reported better-than-expected second-quarter EPS results.</li>
<li>Exicure, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) rose 27% to $0.5090.</li>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) gained 25.4% to $0.2645 after gaining around 8% on Wednesday.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) rose 25.2% to $16.72. The company announced the successful completion of its first five commercial satellites.</li>
<li>Bally&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALY#NYSE">BALY</a>) gained 24.2% to $16.80. Bally&#8217;s entered into merger agreement with affiliates of Standard General L.P.</li>
<li>Molina Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) climbed 18.3% to $341.39 following better-than-expected quarterly earnings.</li>
<li>The Shyft Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHYF#NASDAQ">SHYF</a>) gained 16.4% to $13.55 following upbeat earnings.</li>
<li>Carpenter Technology Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) climbed 16.3% to $141.59 after the company reported better-than-expected quarterly financial results.</li>
<li>Indivior PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDV#NASDAQ">INDV</a>) rose 15.4% to $12.56 after the company posted better-than-expected second-quarter results and announced an accelerated $100 million share repurchase program.</li>
<li>Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) shares climbed 15.4% to $0.3499.</li>
<li>RPC, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RES#NYSE">RES</a>) gained 15.1% to $6.64 following upbeat earnings.</li>
<li>ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) jumped 13.7% to $831.97 after the company reported better-than-expected second-quarter financial results.</li>
<li>Pegasystems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) rose 13.1% to $69.09 after the company reported better-than-expected second-quarter financial results.</li>
<li>Helmerich &amp; Payne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) climbed 12.5% to $42.46 following third-quarter results.</li>
<li>BloomZ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) gained 12.2% to $2.75 after dipping 43% on Wednesday. BloomZ recently priced its IPO at $4.30 per share.</li>
<li>Valmont Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) gained 11.1% to $300.96 following upbeat earnings.</li>
<li>Plexus Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) rose 10.5% to $128.36 following upbeat earnings.</li>
<li>Knight-Swift Transportation Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) rose 10.1% to $53.92 following second-quarter results.</li>
<li>Tyler Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) gained 9.6% to $565.64 after the company reported better-than-expected second-quarter adjusted EPS and sales.</li>
<li>Mr. Cooper Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NYSE">COOP</a>) rose 9.5% to $94.86 following second-quarter results.</li>
<li>Oceaneering International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OII#NYSE">OII</a>) gained 9.2% to $27.79 following strong sales.</li>
<li>RTX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) surged 8% to $113.24 following a second-quarter earnings beat.</li>
<li>J.B. Hunt Transport Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) gained 6.1% to $173.75.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>2U, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWOU#NASDAQ">TWOU</a>) shares dipped 60% to $1.65. 2U announced a strategic agreement with debtholders to eliminate half of debt and infuse $110 million in new capital.</li>
<li>EZFill Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZFL#NASDAQ">EZFL</a>) tumbled 40.3% to $3.73.</li>
<li>Kindly MD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDLY#NASDAQ">KDLY</a>) fell 37.5% to $2.04 after the company submitted comment to the Department of Justice regarding cannabis rescheduling.</li>
<li>Cheetah Net Supply Chain Service Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNT#NASDAQ">CTNT</a>) dipped 34% to $0.3185. Cheetah Net Supply Chain Service announced pricing of $1.49 million follow-on public offering.</li>
<li>MaxLinear, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NYSE">MXL</a>) shares fell 30.7% to $15.45 after the company reported worse-than-expected second-quarter financial results.</li>
<li>Sol-Gel Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLGL#NASDAQ">SLGL</a>) dipped 30% to $0.4750. Sol-Gel announced the signing of six exclusive license agreements to commercialize TWYNEO&#xAE; and EPSOLAY&#xAE; in Europe and South Africa.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) fell 29.7% to $9.49 after declining 10% on Wednesday.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) fell 27% to $0.1159.</li>
<li>Orion Group Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORN#NYSE">ORN</a>) declined 21.9% to $8.62 after the company reported worse-than-expected second-quarter financial results.</li>
<li>Ostin Technology Group Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) shares declined 20.3% to $0.35 after gaining around 19% on Wednesday.</li>
<li>Ribbon Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBBN#NASDAQ">RBBN</a>) tumbled 19.2% to $3.1450 after the company reported worse-than-expected quarterly revenue.</li>
<li>Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) shares fell 16.6% to $11.40 following a second-quarter earnings miss.</li>
<li>Hoth Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOTH#NASDAQ">HOTH</a>) fell 15.1% to $0.9103. Hoth Therapeutics shares gained around 11% on Wednesday after the company signed an agreement with LTS Therapy Systems to develop and manufacture the HT-ALZ oral film prototype for Alzheimer&#8217;s disease.</li>
<li>Garrett Motion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTX#NASDAQ">GTX</a>) declined 13.8% to $7.86 after the company reported worse-than-expected quarterly financial results and lowered its FY24 guidance.</li>
<li>Selina Hospitality PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) shares fell 13.4% to $0.0396 after jumping over 75% on Wednesday.</li>
<li>Kaiser Aluminum Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALU#NASDAQ">KALU</a>) declined 13.3% to $79.76 after the company reported worse-than-expected quarterly financial results.</li>
<li>Hut 8 Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NYSE">HUT</a>) declined 12.8% to $15.71.</li>
<li>LKQ Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) fell 12.1% to $39.10 after the company reported worse-than-expected quarterly adjusted EPS and sales. Additionally, the company lowered its FY24 adjusted EPS outlook.</li>
<li>STMicroelectronics N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STM#NYSE">STM</a>) shares fell 12% to $34.81 after the company reported a second-quarter EPS miss and issued soft third-quarter guidance.</li>
<li>Teradyne, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) dipped 9.7% to $129.30 following soft third-quarter guidance.</li>
<li>West Pharmaceutical Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) fell 9.5% to $292.91 after the company reported a quarterly earnings miss and cut its guidance.</li>
<li>FormFactor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) fell 8.2% to $52.26.</li>
<li>Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) tumbled 8.2% to $249.52 after Citigroup downgraded the stock from a Buy to a Neutral and lowered its price target from $415 to $300.</li>
<li>Robert Half Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHI#NYSE">RHI</a>) declined 7% to $60.32 after the company reported worse-than-expected second-quarter financial results.</li>
<li>Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) fell 6.8% to $18.27 following H1 results.</li>
<li>QuantumScape Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) shares fell 6.2% to $7.01 after the company reported worse-than-expected EPS results.</li>
<li>Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) declined 4.1% to $204.82 after the company lowered FY24 EPS guidance.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39961297/this-lululemon-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-thursday">This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday</a></li>
</ul>

Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Helmerich &amp; Payne, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) shares are trading higher today. The company disclosed the acquisition of KCA Deutag <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39955853/helmerich-payne-announces-agreement-to-acquire-kca-deutag" rel="noreferrer noopener">for $1.9725 billion in cash</a>.
KCA Deutag is a drilling company with a land drilling presence in the Middle East. The acquisition grants Helmerich substantial entry into land operations in the region, where KCA Deutag earned about 70% of its 2023 Operating EBITDA.
The transaction is expected to close before the end of calendar year 2024, pending customary closing conditions.
Post-acquisition, Helmerich&#8217;s Middle East rig count will jump from 12 to 88, with 71 rigs in Saudi Arabia, Oman, and Kuwait, making it one of the region&#8217;s largest rig providers.
The Middle East rig market is projected to grow, and with KCA Deutag&#8217;s ~$5.5 billion contract backlog and strong customer base, H&amp;P will gain resilient revenues and improved earnings visibility.
Synergies: H&amp;P expects this transaction to grow its international land operations from ~1%&nbsp;on a standalone basis to ~19%&nbsp;on a pro forma basis based on calendar year 2023 Operating EBITDA, and also its offshore operations will rise from ~3% to ~7%.
The combined company&#8217;s last-twelve months Operating EBITDA stands at approximately $1.2 billion.
The transaction is anticipated to be immediately accretive to cash flow and free cash flow per share, with double-digit free cash flow accretion expected by 2025. Returns are projected to surpass the cost of capital by 2026.
Despite the minimal geographic overlap, Helmerich anticipates achieving ~$25 million in run-rate synergies by 2026, mainly from overhead <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">reductions and procurement savings</a>.
Post-closure, H&amp;P will have three main operating segments: North America Solutions, International Solutions, and Offshore Solutions, with North America Solutions remaining unchanged.
Yesterday, the company reported third-quarter adjusted EPS of&nbsp;$0.92, above the consensus of&nbsp;$0.77, and revenue&nbsp;of $698 million, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39943466/helmerich-payne-inc-announces-fiscal-third-quarter-results" rel="noreferrer noopener">beating the street view.</a>
As of June 30, the company&#8217;s cash and cash equivalent stood at $203.6 million.
Investors can gain exposure to the stock via Invesco S&amp;P SmallCap Energy ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSCE#NASDAQ">PSCE</a>) and SPDR Series Trust SPDR S&amp;P Oil &amp; Gas Equipment &amp; Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XES#NYSE">XES</a>).
Price Action: HP shares are up 10.4% at $41.70 at the last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock

Helmerich & Payne Makes Big Bet on Middle East with ~$2B KCA Deutag Acquisition

Benchmark analyst Kurt Hallead reiterates Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Hold.

Reiteration

Benchmark Reiterates Hold on Helmerich & Payne

U.S. stocks were higher, with the Dow Jones index gaining more than 1% on Thursday.
Shares of International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) rose during Thursday's session following strong <a href="https://www.benzinga.com/news/24/07/39961144/why-ibm-stock-is-trading-higher-on-thursday">quarterly earnings</a>.
IBM reported quarterly earnings of $2.43 per share, which beat the analyst consensus estimate of $2.19. Quarterly sales clocked in at $15.8 billion, which beat the analyst consensus estimate of $15.616 billion.
IBM shares gained 6.4% to $195.75 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Viking Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) shares surged 28.2% to $64.64 after the company reported better-than-expected second-quarter EPS results.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) jumped 25.2% to $16.72. The company announced the successful completion of its first five commercial satellites.</li>
<li>Bally&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALY#NYSE">BALY</a>) shares rose 24.2% to $16.80. Bally&#8217;s entered into merger agreement with affiliates of Standard General L.P.</li>
<li>Molina Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) gained 18.3% to $341.39 following better-than-expected quarterly earnings.</li>
<li>Carpenter Technology Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) jumped 16.3% to $141.59 after the company reported better-than-expected quarterly financial results.</li>
<li>RPC, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RES#NYSE">RES</a>) rose 15.1% to $6.64 following upbeat earnings.</li>
<li>ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) rose 13.7% to $831.97 after the company reported better-than-expected second-quarter financial results.</li>
<li>Viasat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>) jumped 13.6% to $19.05.</li>
<li>Pegasystems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) gained 13.1% to $69.09 after the company reported better-than-expected second-quarter financial results.</li>
<li>Helmerich &amp; Payne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) gained 12.5% to $42.46 following third-quarter results.</li>
<li>CBRE Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>) surged 11.7% to $109.87 after the company raised its 2024 guidance.</li>
<li>Valmont Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) climbed 11.1% to $300.96 following upbeat earnings.</li>
<li>Lazard, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) rose 11% to $48.08 following better-than-expected quarterly earnings.</li>
<li>Tyler Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) rose 10.7% to $571.01 after the company reported better-than-expected quarterly adjusted EPS and sales.</li>
<li>Plexus Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) gained 10.5% to $128.36 following upbeat earnings.</li>
<li>Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) surged 10.2% to $5.80.</li>
<li>Beam Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) rose 10.1% to $32.81.</li>
<li>Knight-Swift Transportation Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) gained 10.1% to $53.92 following second-quarter results.</li>
<li>Tyler Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) shares climbed 9.6% to $565.64 after the company reported better-than-expected second-quarter adjusted EPS and sales.</li>
<li>Mr. Cooper Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NYSE">COOP</a>) gained 9.5% to $94.86 following second-quarter results.</li>
<li>RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) climbed 9.2% to $121.14 after the company reported better-than-expected quarterly earnings.</li>
<li>Oceaneering International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OII#NYSE">OII</a>) rose 9.2% to $27.79 following strong sales.</li>
<li>Masco Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>) gained 8.1% to $76.27 after the company reported better-than-expected second-quarter earnings.</li>
<li>Universal Health Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) rose 8.1% to $201.00 after the company reported better-than-expected second-quarter earnings and increased FY 2024 guidance.</li>
<li>RTX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) climbed 8% to $113.24 following a second-quarter earnings beat.</li>
<li>Morningstar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MORN#NASDAQ">MORN</a>) rose 7.8% to $328.71. The company reported second-quarter financial results yesterday.</li>
<li>Nasdaq, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) gained 7.4% to $67.36 after the company reported better-than-expected second-quarter financial results.</li>
<li>MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) rose 7.4% to $262.60.</li>
<li>J.B. Hunt Transport Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBHT#NASDAQ">JBHT</a>) shares rose 6.1% to $173.75.</li>
<li>Unilever PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UL#NYSE">UL</a>) gained 5.9% to $59.90 following HI results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39961795/apple-to-rally-around-10-here-are-10-top-analyst-forecasts-for-thursday">Apple To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday</a></li>
</ul>

IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday

WIIM

Helmerich & Payne shares are trading higher after the company reported better-than-expected Q3 financial results. Also, the company announced an agreement to acquire KCA Deutag in a $1.97B cash deal.

<ul>
<li>Establishes H&amp;P as a global leader in onshore drilling</li>
<li>Immediately accretive to cash flow and free cash flow per share</li>
<li>Enhances scale and diversification, now with leading positions in the U.S. and Middle East, the two most prominent oil and gas producing regions in the world</li>
<li>Increases H&amp;P's Middle East rig count(1) from 12 rigs to 88 rigs; positioning the Company as one of the largest rig providers in the Middle East market</li>
<li>Expects to maintain its high-quality investment grade credit rating</li>
<li>Adds complementary, asset-light global offshore management contract business and manufacturing and engineering operations in Europe and Middle East</li>
<li>H&amp;P to host a conference call to discuss its fiscal third quarter results and transaction today at 7:30 a.m. CT</li>
</ul>
Helmerich &amp; Payne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) ("H&amp;P" or the "Company") and KCA Deutag International Limited ("KCA Deutag") today announced a definitive agreement under which H&amp;P will acquire KCA Deutag for $1.9725 billion in cash.

Helmerich & Payne Announces Agreement To Acquire KCA Deutag For $1.9725B In Cash

Earnings

Helmerich & Payne Q3 2024 EPS $0.88 Vs $0.93 Est.; Total Revenue $698M Vs $664.9M Est

Helmerich &amp; Payne, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hp#NYSE">HP</a>) is set to release fiscal third-quarter earnings on Jul 24, after the closing bell. The current Zacks Consensus Estimate for earnings is pegged at 77 cents per share on revenues of $668.8 million.
Let&#39;s delve into the factors that might have influenced HP&#39;s performance in the to-be-reported quarter. Before that, it&#39;s worth taking a look at the company&#39;s performance in the last reported quarter.
<h3>Highlights of Q2 Earnings</h3>
In the last reported quarter, the Tulsa, OK-based oil and gas drilling company&#39;s earnings marginally beat the consensus mark. HP reported adjusted earnings of 86 cents per share, which was one cent higher than the Zacks Consensus Estimate. This was attributed to the strong performance of the International Solutions unit, which reported an operating profit of $3.6 million, surpassing the consensus estimate of a loss of $1.6 million.
Operating revenues of $687.9 million also beat the Zacks Consensus Estimate by 1.2%. HP&#39;s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed the mark in one, delivering an average earnings surprise of 15.53%.
<div class="chart_embed">
<h3>Helmerich &amp; Payne, Inc. Price and EPS Surprise</h3>
<img alt="Helmerich &amp; Payne, Inc. Price and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/0b/1721381890.png" style="height:263px; width:538px" title="" />
Helmerich &amp; Payne, Inc. price-eps-surprise | Helmerich &amp; Payne, Inc. Quote
</div>
<h3>Trend in Estimate Revision</h3>
The Zacks Consensus Estimate for third-quarter fiscal 2024 earnings has witnessed an upward revision and no downward movement in the past 30 days. The estimated figure indicates a 29.36% year-over-year decline. The Zacks Consensus Estimate for revenues indicates a decrease of 7.61% from the year-ago period.
<h3>Factors to Consider</h3>
On a positive note, Helmerich &amp; Payne&lsquo;s operating costs and expenses are projected to have reached $559.5 million in the fiscal third quarter, down 2.7% from the year-ago period&#39;s level. Specifically, the company&#39;s drilling services and other operating expenses are expected to have reduced from $430.2 million to $386.9 million. This reduction in costs highlights the company&#39;s efforts to improve efficiency and control expenses.
On the other hand, HP&#39;s revenues are likely to have been negatively impacted in the quarter to be reported. Our model predicts fiscal third-quarter revenues to decrease to $666.1 million from the year-ago period&#39;s level of $724 million. This decline is due to the weaker performance across North America Solutions, International Solutions, Offshore Gulf of Mexico and Other segments, reflecting challenges in market conditions and segment-specific issues.
<h3>What Does Our Model Predict?</h3>
The proven Zacks model does not conclusively predict an earnings beat for Helmerich &amp; Payne this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. However, that&#39;s not the case here.
Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, for this company is +0.97%.
Zacks Rank:&nbsp; HP currently carries a Zacks Rank #5 (Strong Sell).
<h3>Stocks to Consider</h3>
Here are some firms that you may want to consider, as these have the right combination of elements to post an earnings beat this reporting cycle.
Coterra Energy (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctra#NYSE">CTRA</a>) has an Earnings ESP of +3.01% and a Zacks Rank #2 at present.
The firm is scheduled to release earnings on Aug 1. CTRA has a trailing four-quarter average earnings surprise of 9.81%. Valued at around $20.1 billion, CTRA&#39;s shares have risen 2.2% in a year.
Pembina Pipeline (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pba#NYSE">PBA</a>) currently has an Earnings ESP of +9.09% and a Zacks Rank #2. The firm is scheduled to release earnings on Aug 8.
PBA has a trailing four-quarter average earnings surprise of 10.91%. Valued at around $21.84 billion, PBA&#39;s shares have risen 21.9% in a year.
Baker Hughes (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bkr#NASDAQ">BKR</a>) has an Earnings ESP of +1.59% and a Zacks Rank #3 at present. The firm is scheduled to release earnings on Jul 25.
BKR has a trailing four-quarter average earnings surprise of 11.4%. &nbsp;Valued at around $36.09 billion, BKR&#39;s shares have risen 2% in a year.
<a href="https://www.zacks.com/stock/news/2305056/what-s-in-store-for-helmerich-payne-hp-in-q3-earnings?cid=CS-BENZ-FT-analyst_blog|earnings_preview-2305056">To read this article on Zacks.com click here.</a>

Earnings Beats

CTRA

What's in Store for Helmerich & Payne in Q3 Earnings?

B of A Securities analyst Chase Mulvehill maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Buy and lowers the price target from $42.5 to $40.

B of A Securities Maintains Buy on Helmerich & Payne, Lowers Price Target to $40

Ratings for Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) were provided by 3 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $41.67, a high estimate of $50.00, and a low estimate of $36.00. A decline of 7.4% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1721044885_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A clear picture of Helmerich &amp; Payne's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ian Macpherson</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$36.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Ian Macpherson</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$39.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Charles Minervino</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$50.00</td>
<td>$52.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Helmerich &amp; Payne. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Helmerich &amp; Payne compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Helmerich &amp; Payne's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Helmerich &amp; Payne's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Helmerich &amp; Payne analyst ratings.</a>
<h2>Delving into Helmerich &amp; Payne's Background</h2>
Helmerich &amp; Payne maintains one of the largest fleets of land drilling rigs in the US. The company's FlexRig line is the leading choice to drill horizontal wells for production of US tight oil and gas. H&amp;P is present in nearly every major US shale play and has a small but growing presence internationally.
<h3>Understanding the Numbers: Helmerich &amp; Payne's Finances</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Decline in Revenue: Over the 3 months period, Helmerich &amp; Payne faced challenges, resulting in a decline of approximately -10.57% in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Energy sector.
Net Margin: Helmerich &amp; Payne's net margin is impressive, surpassing industry averages. With a net margin of 12.15%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Helmerich &amp; Payne's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.01% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Helmerich &amp; Payne's ROA excels beyond industry benchmarks, reaching 1.89%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.19.
<h2>The Basics of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

3 Analysts Assess Helmerich & Payne: What You Need To Know

Piper Sandler analyst Ian Macpherson maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Neutral and lowers the price target from $39 to $36.

Piper Sandler Maintains Neutral on Helmerich & Payne, Lowers Price Target to $36

DELL

MRVL

MSFT

NVDA

QCOM

New AI PCs May Take Years To Make Sales Impact; Microsoft, Dell, HP Among Makers Highlighting AI PCs; Only 3% Of PCs Shipped In 2024 Will Be AI-Optimized

Growth stocks are experiencing a remarkable resurgence, posting their best month in over a year when compared to value stocks, as the rally in tech and mega caps continues<a href="https://www.benzinga.com/markets"> to dominate market dynamics. </a>
The iShares Russell 1000 Growth ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWF#NYSE">IWF</a>) has surged by 6.5% so far in June 2024. This gain puts it on track for its seventh month of increases in the last eight.
Investors have shown elevated confidence in growth-oriented sectors, particularly technology, which continues to benefit from strong earnings reports, heightened expectations for future cash flows and positive market sentiment, especially towards AI-related industries.
In stark contrast, the iShares Russell 1000 Value ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWD#NYSE">IWD</a>), representing the other major equity style, has declined by 1.4% in June. 
This divergence highlights the challenges facing value stocks, which typically encompass sectors like financials, energy, utilities, and consumer staples. These sectors have struggled to attract investor interest due to their less impressive performance and subdued earnings expectations.
The performance gap between growth and value in June 2024 stands at a striking 7.9 percentage points, marking the most substantial monthly performance difference since May 2023. 
With one trading week remaining in the month, if the gap exceeds 9.6 percentage points, previously reached in March 2020, it will mark the largest one-month outperformance of growth over value ever recorded.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="500" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/21143747/image-50-1024x500.png" alt="" class="wp-image-400005" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/21143747/image-50-1024x500.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/21143747/image-50-300x147.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/21143747/image-50-768x375.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/21143747/image-50-1536x750.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/21143747/image-50.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">4 Key Factors Driving Growth&#8217;s Outperformance Over Value</h3>
Technology Sector&#8217;s Dominance in Growth ETFs: The technology sector&#8217;s heavy weighting in growth-related ETFs has been the main driver of their outperformance. In the Russell 1000 Growth ETF, tech stocks comprise a substantial 47% of the portfolio. In stark contrast, the Russell 1000 Value ETF allocates only 9.5% to tech stocks.
Impact of Chipmakers on Growth Performance: Within the tech sector, the substantial weighting of chipmakers in growth funds has been another critical factor, as they have been the main beneficiaries of the current AI-driven rally. The semiconductor sector represents 17% of the growth ETF, compared to a mere 4.2% in the value ETF.
Absence of Nvidia, Magnificent 6 In Value ETFs: Notably, &#8220;The Magnificent 6&#8221; – as named by Bank of America – Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>), Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Amazon Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), and Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) – are absent from the value-linked ETF but collectively hold a 50% weight in the growth ETF.
Stock Concentration and Market Breadth Differences: The higher stock concentration in growth-related ETFs compared to value socks is another crucial factor, especially in the current context of poor market breadth. The top 10 stocks in the Russell 1000 Growth ETF comprise 57% of the overall portfolio, whereas the top 10 in the value-related ETF account for only 17% of the total weight.
<h3 class="wp-block-heading">Top 7 Performing Growth Stocks In June</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Name</td>
<td>Price Chg. % (MTD)</td>
</tr>
<tr>
<td>Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>)</td>
<td>26.85%</td>
</tr>
<tr>
<td>Texas Pacific Land Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPL#NYSE">TPL</a>)</td>
<td>22.95%</td>
</tr>
<tr>
<td>Sarepta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>)</td>
<td>22.88%</td>
</tr>
<tr>
<td>Adobe Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>)</td>
<td>19.95%</td>
</tr>
<tr>
<td>Oracle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>)</td>
<td>19.91%</td>
</tr>
<tr>
<td>CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>)</td>
<td>19.48%</td>
</tr>
<tr>
<td>Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>)</td>
<td>19.04%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">As of June 21, 2024</figcaption></figure>
<h2 class="wp-block-heading">Top 7 Performing Value Stocks In June</h2>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Name</td>
<td>Price Chg. % (MTD)</td>
</tr>
<tr>
<td>Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>)</td>
<td>24.68%</td>
</tr>
<tr>
<td>DC Technology Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXC#NYSE">DXC</a>)</td>
<td>20.23%</td>
</tr>
<tr>
<td>Guidewire Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>)</td>
<td>19.58%</td>
</tr>
<tr>
<td>Universal Display Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLED#NASDAQ">OLED</a>)</td>
<td>18.71%</td>
</tr>
<tr>
<td>Ollie&#8217;s Bargain Outlet Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>)</td>
<td>18.52%</td>
</tr>
<tr>
<td>Zillow Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NYSE">ZG</a>)</td>
<td>17.88%</td>
</tr>
<tr>
<td>Hewlett Packard Enterprise Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>)</td>
<td>16.29%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">As of June 21, 2024</figcaption></figure>
Read now: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39431836/5-charts-expose-troubling-weaknesses-in-record-high-stock-market-this-is-not-normal">5 Charts Expose Troubling Weaknesses In Record-High Stock Market: &#8216;This Is Not Normal&#8217;</a>
Image created using artificial intelligence via Midjourney.

Analyst Color

Large Cap

Sector ETFs

Broad U.S. Equity ETFs

Small Cap

Tech

ETFs

AAPL

ADBE

ADSK

AMZN

AVGO

COHR

CRWD

GOOG

GOOGL

GWRE

OLED

OLLI

ORCL

SRPT

Growth Stocks Leave Value Stocks In The Dust: 4 Reasons For Biggest Monthly Lead In Over A Year

AESI

CIVI

CLNE

FANG

LBRT

MTDR

NCSM

PNRG

PTEN

TALO

WFRD

Shares of several oil & gas companies are trading lower following an OPEC+ meeting in which members said they would start phasing out voluntary production cuts in October.

Berkshire Dissolves Stake In HP

Piper Sandler analyst Ian Macpherson maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Neutral and lowers the price target from $44 to $39.

Piper Sandler Maintains Neutral on Helmerich & Payne, Lowers Price Target to $39

Susquehanna analyst Charles Minervino maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Positive and lowers the price target from $52 to $50.

Susquehanna Maintains Positive on Helmerich & Payne, Lowers Price Target to $50

In the last three months, 6 analysts have published ratings on Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>), offering a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $47.67, a high estimate of $52.00, and a low estimate of $42.00. Observing a 5.0% increase, the current average has risen from the previous average price target of $45.40. 
<img src="https://www.benzinga.com/files/images/story/2024/1714068072_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Helmerich &amp; Payne. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$42.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Charles Minervino</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$52.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Charles Minervino</td>
<td>Susquehanna</td>
<td>Maintains</td>
<td>Positive</td>
<td>$50.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Ian Macpherson</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$44.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Charles Minervino</td>
<td>Susquehanna</td>
<td>Maintains</td>
<td>Positive</td>
<td>$50.00</td>
<td>-</td>
</tr>
<tr>
<td>Keith Mackey</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$48.00</td>
<td>$46.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Helmerich &amp; Payne. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Helmerich &amp; Payne compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Helmerich &amp; Payne's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Helmerich &amp; Payne's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/HP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Helmerich &amp; Payne analyst ratings.</a>
<h2>Delving into Helmerich &amp; Payne's Background</h2>
Helmerich &amp; Payne maintains one of the largest fleets of land drilling rigs in the U.S. The company's FlexRig line is the leading choice to drill horizontal wells for production of U.S. tight oil and gas. H&amp;P is present in nearly every major U.S. shale play and also has a small but growing presence internationally.
<h3>A Deep Dive into Helmerich &amp; Payne's Financials</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Helmerich &amp; Payne's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2023, the company experienced a revenue decline of approximately -5.9%. This indicates a decrease in the company's top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Helmerich &amp; Payne's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 13.87%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Helmerich &amp; Payne's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 3.4%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Helmerich &amp; Payne's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.13% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Helmerich &amp; Payne's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.2.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Helmerich & Payne Stock

Helmerich & Payne beats top-line and bottom-line estimates; initiates Q4 outlook

Helmerich & Payne declares $0.25 dividend

Benchmark Co. analyst Kurt Hallead maintained a Hold rating on Helmerich & Payne (HP – Research Report) today. The company's shares closed yesterda...

Helmerich & Payne (HP) Gets a Hold from Benchmark Co.

Analysts have been eager to weigh in on the Energy sector with new ratings on Helmerich & Payne (HP – Research Report), Vitesse Energy, Inc. (VTS –...

Analysts Conflicted on These Energy Names: Helmerich & Payne (HP), Vitesse Energy, Inc. (VTS) and Helix Energy (HLX)

Helmerich & Payne to acquire KCA Deutag for $1.97B in cash

Helmerich & Payne (HP) just unveiled an announcement. Helmerich & Payne, Inc. has entered into an agreement to acquire KCA Deutag for approximately...

Helmerich & Payne Announces Strategic Acquisition of KCA Deutag

Helmerich & Payne, Inc. 2024 Q2 - Results - Earnings Call Presentation

Helmerich & Payne, Inc. (HP) Q3 2024 Earnings and Acquisition of KCA Deutag Call Transcript

Analysts fell to the sidelines weighing in on Helmerich & Payne (HP – Research Report) and Ampol Limited (CTXAF – Research Report) with neutral rat...

Analysts Offer Insights on Energy Companies: Helmerich & Payne (HP) and Ampol Limited (OtherCTXAF)

In a report released yesterday, James West from Evercore ISI maintained a Buy rating on Helmerich & Payne (HP – Research Report), with a price targ...

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Helmerich & Payne

Helmerich & Payne (HP) Forecast

Helmerich & Payne (NYSE:HP) Stock, Quote.Headers.trade-ideas